LONDON, March 21 (Reuters) - British Biotech Plc, a former flagship of the UK biotechnology sector brought low by drug failures, said on Friday it had agreed to merge with privately-owned RiboTargets.
The deal will create a business with a market value of around 52 million pounds ($81.5 million), and will aim at making around 6.4 million pounds of cash-savings per year, including reducing headcount from 177 to around 110 employees.

The first tick up for some time today after a good size deals at middle price

not been looking since the merger but as you say volumes are much higher than recent although not exceptional.

After good volume on the last couple days, yesterday had good move up and today is following that revival now 67-70p

There is a revival on some Biotechnology shares for the last few days, something is going on at the sector, and someone is buying on inside knowledge.

I do remember hearing last weekeng on Bloomberg TV someone commenting about some consolidation should be talking place on the Bio sector.

Yes ... there is a lot of talk about the need/desireability of consolidation